• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • 中文 (中国)
  • English
Worcester HIV Vaccine

Worcester HIV Vaccine

  • Home
  • Our Science
    • PDPHV candidate
    • Vaccine approach
    • Our Clinical Trials
    • Preclinical studies
    • Publications
  • About WHV
    • Our Mission
    • Our History
    • Our Team
    • Our Advisors
    • Safety Monitoring Board
  • News
  • Contact us

HVTN 124 trial is fully enrolled

February 13, 2019

The HVTN 124 team completed enrollment of all 60 volunteers scheduled for the trial. Vaccinations will continue through October of 2019.

Learn more about the HVTN 124 trial

Filed Under: HVTN 124, News

Footer

© 2019 Worcester HIV Vaccine

WHV Logo